BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 9, 2009
View Archived Issues
Anadys Soars 115 percent on Strong Hepatitis C Virus Data
Read More
Senate HELP Committee Grills Daschle about Health Reform
Read More
Vivaldi Raises $23M Financing for Older Adult Flu Vaccines
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Pharma Still Keen for Vaccines; Wyeth, Crucell in Merger Talks
Dutch vaccines maker Crucell NV confirmed that it was talking to Wyeth about a possible merger after reports surfaced Wednesday afternoon that the big pharma firm was interested in an acquisition. (BioWorld Today)
Read More
Plexxikon Rejoins with Roche in $335M Deal for Raf Inhibitors
Read More